Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjögren's syndrome

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 241-247

  Roguedas, Anne Marie ^a   Pers, Jacques Olivier ^a,b   Lemasson, Gilles ^a   Devauchelle, Valérie ^a,b   Tobón, Gabriel J ^b   Saraux, Alain ^a,b   Misery, Laurent ^a   Youinou, Pierre ^a,b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b Universite de Brest   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA; CELL AGGREGATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRY SKIN; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; MEMORY CELL; PRIORITY JOURNAL; PUNCH BIOPSY; SALIVARY GLAND; SJOEGREN SYNDROME; SKIN BIOPSY; SKIN INFILTRATE; SWEAT GLAND; VISUAL ANALOG SCALE; XEROSIS;

EID: 77957757039     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.014     Document Type: Article

References (75)

1. Moutsopoulos H.M. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994, 72:162-165.
2. Bourazopoulou E., Kapsogeorgou E.K., Routsias J.G., Manoussakis M.N., Moutsopoulos H.M., Tzioufas A.G. Functional expression of the alpha 2-macroglobulin receptor CD91 in salivary gland epithelial cells. J Autoimmun 2009, 33:141-146.
3. Christodoulou MI, Kapsageorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun 2010;34:400-7.
4. Hay E.M., Thomas E., Pal B., Hajeer A., Chambers H., Silman A.J. Weak association between subjective symptoms and objective testing for dry eyes and dry mouth: results from a population-based study. Ann Rheum Dis 1998, 57:20-24.
5. Chiorini J.A., Cihakova D., Ouellette C.E., Caturegli P. Sjögren's syndrome: advances in the pathogenesis from animal models. J Autoimmun 2009, 33:190-196.
6. Pérez P., Anaya J.M., Aguilera S., Urzúa U., Munroe D., Molina C., et al. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J Autoimmun 2009, 33:99-108.
7. Youinou P., Jamin C. The weight of interleukin-6 in B cell-related autoimmune disorders. J Autoimmun 2009, 32:206-210.
8. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
9. Roguedas A.M., Misery L., Sassolas B., Le Masson G., Pennec Y.L., Youinou P. Cutaneous manifestations of primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol 2004, 22:632-636.
10. Vivino F.B., Gala I., Hermann G.A. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002, 29:938-944.
11. Radfar L., Kleiner D.E., Fox P.C., Pillemer S.R. Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 2002, 47:520-524.
12. Leroy J.P., Pennec Y.L., Soulier C., Berthelot J.M., Letoux G., Youinou P. Follow up study of labial salivary gland lesions in primary Sjögren's syndrome. Ann Rheum Dis 1992, 51:777-780.
13. Leroy J.P., Pennec Y.L., Letoux G., Youinou P. Lymphocytic infiltration of salivary ducts: a histopathologic lesion specific for primary Sjögren's syndrome?. Arthritis Rheum 1992, 35:481-482.
14. Pijpe J., Kalk W.W., van der Wal J.E., Vissink A., Kluin P.M., Roodenburg J.L., et al. Parotid gland biopsy compared with labial biopsy in the diagnosis primary Sjögren's syndrome. Rheumatology (Oxford) 2007, 46:335-341.
15. Pennec Y.L., Leroy J.P., Jouquan J., Lelong A., Katsikis P., Youinou P. Comparison of labial and sublingual salivary gland biopsies in the diagnosis of Sjögren's syndrome. Ann Rheum Dis 1990, 49:37-39.
16. Hansen A., Lipsky P.E., Do{double acute}rner T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007, 9:218-230.
17. Sigmundsdottir H., Butcher E.C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 2008, 9:981-987.
18. Daniels T.E., Whitcher J.P. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994, 37:869-877.
19. Sato K., Leidal R., Sato F. Morphology and development of an apoeccrine sweat gland in human axillae. Am J Physiol 1987, 252:R166-R180.
20. Binard A., Devauchelle V., Fautrel B., Jousse S., Youinou P., Saraux A. Epidemiology of Sjögren's syndrome: where are we now?. Clin Exp Rheumatol 2007, 25:1-4.
21. Pijpe J., van Imhoff G.W., Spijkervet F.K., Roodenburg J.L., Wolbink G.J., Mansour K., et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Arthritis Rheum 2005, 52:2740-2750.
22. Devauchelle-Pensec V., Pennec Y., Morvan J., Pers J.O., Daridon C., Jousse-Joulin S., et al. Improvement of Sjögren's syndrome after two infusions of rituximab. Arthritis Rheum 2007, 57:310-317.
23. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36:340-347.
24. Do{double acute}rner T., Lipsky P.E. Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome. Arthritis Res 2002, 4:360-371.
25. Looney R.J. Will targeting B cells be the answer for Sjögren's syndrome?. Arthritis Rheum 2007, 56:1371-1377.
26. Youinou P., Devauchelle V., Hutin P., Le Berre R., Saraux A., Pers J.O. A conspicuous role for B cells in Sjögren's syndrome. Clin Rev Allergy Immunol 2007, 32:231-237.
27. Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994, 180:329-339.
28. d'Arbonneau F., Pers J.O., Devauchelle V., Pennec Y., Saraux A., Youinou P. BAFF induced changes in BCR-containing lipid rafts in Sjögren's syndrome. Arthritis Rheum 2006, 54:115-126.
29. Bohnhorst J.O., Bjorgan M.B., Thoen J.E., Natvig J.B., Thompson K.M. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B-cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001, 167:3610-3618.
30. Hansen A., Odendahl M., Reiter K., Jacobi A.M., Feist E., Scholze J., et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002, 46:2160-2171.
31. Binard A., Le Pottier L., Devauchelle-Pensec V., Saraux A., Youinou P., Pers J.O. Is the blood B-cell subset profile diagnostic for Sjogren syndrome?. Ann Rheum Dis 2009, 68:1447-1452.
32. Dawson L., Tobin A., Smith P., Gordon T. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?. Arthritis Rheum 2005, 52:2984-2995.
33. Pers J.O., Devauchelle V., Daridon C., Bendaoud B., Le Berre R., Bordron A., et al. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome. Arthritis Rheum 2007, 56:1464-1477.
34. Delaleu N., Immervoll H., Cornelius J., Jonsson R. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 2008, 10:R22.
35. Hansen A., Reiter K., Ziprian T., Jacobi A., Hoffmann A., Gosemann M., et al. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome. Arthritis Rheum 2005, 52:2109-2119.
36. Martin F., Kearney J.F. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001, 13:195-201.
37. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002, 109:59-68.
38. Daridon C., Pers J.O., Devauchelle V., Martins-Carvalho C., Hutin P., Pennec Y.L., et al. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2006, 54:2280-2288.
39. Carsetti R., Kohler G., Lamers M.C. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995, 181:2129-2140.
40. Sater R.A., Sandel P.C., Monroe J.G. B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 1998, 10:1673-1682.
41. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182:3540-3547.
42. Do{double acute}rner T., Jacobi A.M., Lipsky P.E. B cells in autoimmunity. Arthritis Res Ther 2009, 11:247.
43. Ardesjo B., Hansson C.M., Bruder C.E., Rorsman F., Betterle C., Dumanski J.P., et al. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. J Autoimmun 2008, 30:273-282.
44. Bikker A., van Woerkom J.M., Kruize A.A., Wenting-van Wijk M., de Jager W., Bijlsma J.W., et al. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjogren's syndrome correlates with increased inflammation. Arthritis Rheum 2010, 62:969-977.
45. Caporali R., Bonacci E., Epis O., Bobbio-Pallavicini F., Morbini P., Montecucco C. Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum 2008, 59:714-720.
46. Ceribelli A., Cavazzana I., Cattaneo R., Franceschini F. Hepatitis C virus infection and primary Sjogren's syndrome: a clinical and serologic description of 9 patients. Autoimmun Rev 2008, 8:92-94.
47. Dai S.M., Han X.H., Li Z.S. Hypertrophic gastritis in early stages of primary Sjogren's syndrome. Arthritis Rheum 2008, 59:1191-1193.
48. Daniels T.E., Criswell L.A., Shiboski C., Shiboski S., Lanfranchi H., Dong Y., et al. An early view of the international Sjogren's syndrome registry. Arthritis Rheum 2009, 61:711-714.
49. Delaleu N., Madureira A.C., Immervoll H., Jonsson R. Inhibition of experimental Sjogren's syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum 2008, 58:2318-2328.
50. Deshmukh U.S., Ohyama Y., Bagavant H., Guo X., Gaskin F., Fu S.M. Inflammatory stimuli accelerate Sjogren's syndrome-like disease in (NZB × NZW)F1 mice. Arthritis Rheum 2008, 58:1318-1323.
51. Ewert P., Aguilera S., Alliende C., Kwon Y.J., Albornoz A., Molina C., et al. Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum 2010, 62:1280-1289.
52. Guzman Moreno R. B-cell depletion in autoimmune diseases. Advances in autoimmunity. Autoimmun Rev 2009, 8:585-590.
53. Hemminki K., Li X., Sundquist J., Sundquist K. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009, 60:661-668.
54. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., Lopez-Guzman S., Mantilla R.D., Chalem P., et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008, 31:156-159.
55. Kabalak G., Dobberstein S.B., Matthias T., Reuter S., The Y.H., Dorner T., et al. Association of immunoglobulin-like transcript 6 deficiency with Sjogren's syndrome. Arthritis Rheum 2009, 60:2923-2925.
56. Kovacs L., Szodoray P., Kiss E. Secondary tumours in Sjogren's syndrome. Autoimmun Rev 2010, 9:203-206.
57. Marcos M., Alvarez F., Brito-Zeron P., Bove A., Perez-De-Lis M., Diaz-Lagares C., et al. Chronic hepatitis B virus infection in Sjogren's syndrome. Prevalence and clinical significance in 603 patients. Autoimmun Rev 2009, 8:616-620.
58. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010, 9:A305-A310.
59. Meijer J.M., Meiners P.M., Vissink A., Spijkervet F.K., Abdulahad W., Kamminga N., et al. Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010, 62:960-968.
60. Meijer J.M., Schonland S.O., Palladini G., Merlini G., Hegenbart U., Ciocca O., et al. Sjogren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity?. Arthritis Rheum 2008, 58:1992-1999.
61. Miceli-Richard C., Gestermann N., Ittah M., Comets E., Loiseau P., Puechal X., et al. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjogren's syndrome. Arthritis Rheum 2009, 60:1991-1997.
62. Pereira R.M., de Carvalho J.F., Bonfa E. Metabolic syndrome in rheumatological diseases. Autoimmun Rev 2009, 8:415-419.
63. Reed J.H., Jackson M.W., Gordon T.P. B cell apotopes of the 60-kDa Ro/SSA and La/SSB autoantigens. J Autoimmun 2008, 31:263-267.
64. Rojas-Villarraga A., Toro C.E., Espinosa G., Rodriguez-Velosa Y., Duarte-Rey C., Mantilla R.D., et al. Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev 2010, 9:229-232.
65. Ronnelid J., Barbasso Helmers S., Storfors H., Grip K., Ronnblom L., Franck-Larsson K., et al. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 2009, 9:58-61.
66. Schulte-Pelkum J., Fritzler M., Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 2009, 8:632-637.
67. Segal B., Thomas W., Rogers T., Leon J.M., Hughes P., Patel D., et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren's syndrome. Arthritis Rheum 2008, 59:1780-1787.
68. Thomas P.B., Zhu Z., Selvam S., Samant D.M., Stevenson D., Mircheff A.K., et al. Autoimmune dacryoadenitis and keratoconjunctivitis induced in rabbits by subcutaneous injection of autologous lymphocytes activated ex vivo against lacrimal antigens. J Autoimmun 2008, 31:116-122.
69. Tobon G.J., Pers J.O., Youinou P., Saraux A. B cell-targeted therapies in Sjogren's syndrome. Autoimmun Rev 2010, 9:224-228.
70. Varin M.M., Le Pottier L., Youinou P., Saulep D., Mackay F., Pers J.O. B-cell tolerance breakdown in Sjogren's syndrome: focus on BAFF. Autoimmun Rev 2010.
71. Vinagre F., Santos M.J., Prata A., da Silva J.C., Santos A.I. Assessment of salivary gland function in Sjogren's syndrome: the role of salivary gland scintigraphy. Autoimmun Rev 2009, 8:672-676.
72. Vosters J.L., Landek-Salgado M.A., Yin H., Swaim W.D., Kimura H., Tak P.P., et al. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome. Arthritis Rheum 2009, 60:3633-3641.
73. Yoon K.C., De Paiva C.S., Qi H., Chen Z., Farley W.J., Li D.Q., et al. Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice. J Autoimmun 2008, 30:212-221.
74. Youinou P., Devauchelle V., Pers J.O. Significance of B cells and B cell clonality in Sjogren's syndrome. Arthritis Rheum 2010.
75. Youinou P., Taher T.E., Pers J.O., Mageed R.A., Renaudineau Y. B lymphocyte cytokines and rheumatic autoimmune disease. Arthritis Rheum 2009, 60:1873-1880.